BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32865663)

  • 1. Antioxidant Modulation of mTOR and Sirtuin Pathways in Age-Related Neurodegenerative Diseases.
    Abdullah A; Mohd Murshid N; Makpol S
    Mol Neurobiol; 2020 Dec; 57(12):5193-5207. PubMed ID: 32865663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longevity Pathways (mTOR, SIRT, Insulin/IGF-1) as Key Modulatory Targets on Aging and Neurodegeneration.
    Mazucanti CH; Cabral-Costa JV; Vasconcelos AR; Andreotti DZ; Scavone C; Kawamoto EM
    Curr Top Med Chem; 2015; 15(21):2116-38. PubMed ID: 26059361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration.
    Querfurth H; Lee HK
    Mol Neurodegener; 2021 Jul; 16(1):44. PubMed ID: 34215308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition.
    de Cavanagh EM; Inserra F; Ferder L
    Am J Physiol Heart Circ Physiol; 2015 Jul; 309(1):H15-44. PubMed ID: 25934099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fighting neurodegeneration with rapamycin: mechanistic insights.
    Bové J; Martínez-Vicente M; Vila M
    Nat Rev Neurosci; 2011 Jul; 12(8):437-52. PubMed ID: 21772323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.
    Maiese K
    Curr Neurovasc Res; 2017; 14(3):299-304. PubMed ID: 28721811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.
    Maiese K
    Biochem Soc Trans; 2018 Apr; 46(2):351-360. PubMed ID: 29523769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirtuin deacetylases in neurodegenerative diseases of aging.
    Herskovits AZ; Guarente L
    Cell Res; 2013 Jun; 23(6):746-58. PubMed ID: 23689277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy.
    Perluigi M; Di Domenico F; Butterfield DA
    Neurobiol Dis; 2015 Dec; 84():39-49. PubMed ID: 25796566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic role of sirtuins in neurodegenerative disease.
    Outeiro TF; Marques O; Kazantsev A
    Biochim Biophys Acta; 2008 Jun; 1782(6):363-9. PubMed ID: 18373985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An insight into the role of autophagy in cell responses in the aging and neurodegenerative brain.
    Caballero B; Coto-Montes A
    Histol Histopathol; 2012 Mar; 27(3):263-75. PubMed ID: 22237704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Target of Rapamycin Signalling Pathway in Ageing and Lifespan Regulation.
    Bjedov I; Rallis C
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin.
    Maiese K
    Curr Neurovasc Res; 2017; 14(2):184-189. PubMed ID: 28294062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel compounds for the modulation of mTOR and autophagy to treat neurodegenerative diseases.
    Heras-Sandoval D; Pérez-Rojas JM; Pedraza-Chaverri J
    Cell Signal; 2020 Jan; 65():109442. PubMed ID: 31639492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders.
    Jęśko H; Wencel P; Strosznajder RP; Strosznajder JB
    Neurochem Res; 2017 Mar; 42(3):876-890. PubMed ID: 27882448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of mTOR in age-related diseases.
    Chrienova Z; Nepovimova E; Kuca K
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1679-1693. PubMed ID: 34309456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity.
    Calabrese V; Cornelius C; Mancuso C; Pennisi G; Calafato S; Bellia F; Bates TE; Giuffrida Stella AM; Schapira T; Dinkova Kostova AT; Rizzarelli E
    Neurochem Res; 2008 Dec; 33(12):2444-71. PubMed ID: 18629638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.
    Maiese K
    Br J Clin Pharmacol; 2016 Nov; 82(5):1245-1266. PubMed ID: 26469771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ageing and neurodegenerative diseases.
    Hung CW; Chen YC; Hsieh WL; Chiou SH; Kao CL
    Ageing Res Rev; 2010 Nov; 9 Suppl 1():S36-46. PubMed ID: 20732460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration.
    Heras-Sandoval D; Pérez-Rojas JM; Hernández-Damián J; Pedraza-Chaverri J
    Cell Signal; 2014 Dec; 26(12):2694-701. PubMed ID: 25173700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.